These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 6243527

  • 1. Decreased renal function in association with administration of 1,25-dihydroxyvitamin D3 to patients with stable, advanced renal failure.
    Christiansen C, Røodbro P, Christensen MS, Naestoft J, Hartnack B, Transbøol I.
    Contrib Nephrol; 1980; 18():139-46. PubMed ID: 6243527
    [Abstract] [Full Text] [Related]

  • 2. Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol.
    Christiansen C, Rødbro P, Christensen MS, Hartnack B, Transbøl I.
    Lancet; 1978 Sep 30; 2(8092 Pt 1):700-3. PubMed ID: 80633
    [Abstract] [Full Text] [Related]

  • 3. 1,25 dihydroxycholecalciferol effects in chronic dialysis. A double-blind controlled study.
    Berl T, Berns AS, Hufer WE, Hammill K, Alfrey AC, Arnaud CD, Schrier RW.
    Ann Intern Med; 1978 Jun 30; 88(6):774-80. PubMed ID: 208439
    [Abstract] [Full Text] [Related]

  • 4. Controlled trial of the effects of 1,25-dihydroxycholecalciferol in patients treated with regular dialysis.
    Berl T, Berns AS, Huffer WE, Alfrey AC, Arnaud CD, Schrier RR.
    Contrib Nephrol; 1980 Jun 30; 18():72-81. PubMed ID: 6243528
    [Abstract] [Full Text] [Related]

  • 5. The effect of 1alpha(OH)D3 and 1alpha,25(OH)2D3 on the bone in patients with renal osteodystrophy.
    Bordier P, Zingraff J, Gueris J, Jungers P, Marie P, Pechet M, Rasmussen H.
    Am J Med; 1978 Jan 30; 64(1):101-7. PubMed ID: 623125
    [Abstract] [Full Text] [Related]

  • 6. A possible direct effect of 24,25-dihydroxycholecalciferol on the parathyroid gland in patients with chronic renal failure.
    Christiansen C, Rødbro P, Naestoft J, Christensen MS.
    Clin Endocrinol (Oxf); 1981 Sep 30; 15(3):237-42. PubMed ID: 6273028
    [Abstract] [Full Text] [Related]

  • 7. The kidney as an endocrine organ involved in the function of vitamin D.
    DeLuca HF.
    Am J Med; 1975 Jan 30; 58(1):39-47. PubMed ID: 163578
    [Abstract] [Full Text] [Related]

  • 8. Comparison of 1,25(OH)2D3 and 24,25(OH)2D3 in the long-term treatment of renal osteodystrophy.
    Muirhead N, Catto GR, Edward N, Fraser RA, O'Riordan JL, Papapoulos SE, Adami S.
    Proc Eur Dial Transplant Assoc; 1980 Jan 30; 17():543-7. PubMed ID: 6972529
    [Abstract] [Full Text] [Related]

  • 9. 1 alpha-hydroxy vitamin D3 treatment of non-dialyzed patients with chronic renal failure. Effects on bone, mineral metabolism and kidney function.
    Nielsen HE, Rømer FK, Melsen F, Christensen MS, Hansen HE.
    Clin Nephrol; 1980 Mar 30; 13(3):103-8. PubMed ID: 7379358
    [Abstract] [Full Text] [Related]

  • 10. Comparative therapeutic effects of vitamin D3 and its derivatives on experimental renal osteodystrophy.
    Fukushima M, Niki R, Ohkawa H, Shimizu T, Matsunaga I, Nakano H, Takagaki Y, Nishii Y, Okano K, Suda T.
    Endocrinology; 1980 Jul 30; 107(1):328-33. PubMed ID: 6247140
    [Abstract] [Full Text] [Related]

  • 11. Use of 1,25(OH)2-vitamin D3 in prevention of renal osteodystrophy: preliminary observations.
    Baker LR, Muir JW, Cattell WR, Tucker KA, Sharman VL, Goodwin FJ, Marsh FP, Hately W, Morgan AG, de Saintonge DM.
    Contrib Nephrol; 1980 Jul 30; 18():147-51. PubMed ID: 7353373
    [Abstract] [Full Text] [Related]

  • 12. 1-alpha-hydroxyvitamin D3 in chronic renal failure. A potent analogue of the kidney hormone, 1,25-dihydroxycholecalciferol.
    Chan JC, Oldham SB, Holick MF, DeLuca HF.
    JAMA; 1975 Oct 06; 234(1):47-52. PubMed ID: 1174223
    [Abstract] [Full Text] [Related]

  • 13. Current status of the use of 1,25(OH)2D3 in the management of renal osteodystrophy.
    Massry SG, Goldstein DA, Malluche HH.
    Kidney Int; 1980 Oct 06; 18(4):409-18. PubMed ID: 7014981
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An evaluation of 1 alpha-hydroxy-and 1,25-dihydroxyvitamin D3 in the treatment of renal bone disease.
    Kanis JA, Russell RG, Cundy T, Earnshaw M, Woods CG, Smith R, Heynen G.
    Contrib Nephrol; 1980 Oct 06; 18():12-28. PubMed ID: 7353370
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Aminoaciduria in chronic renal failure--its relationship to vitamin D and parathyroid status.
    Phillips ME, Havard J, Otterud B.
    Am J Clin Nutr; 1980 Jul 06; 33(7):1541-5. PubMed ID: 6893104
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.